Hims & Hers Health is upgraded to a speculative Buy after a 20% drop, with growth potential in GLP-1 sales outweighing key ...

HIMS accelerates global expansion with tech-integrated care, leveraging ZAVA and semaglutide for personalized health delivery.

Technological innovation and personalized care are transforming Hims & Hers into a proactive health platform. Read why I ...

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of ...

Progressive activists in Hassan demand timely opening of super speciality hospital for improved health services.

Novo Nordisk’s head of U.S. marketing, Ulrich Otte, is no longer in the role and is exploring other internal opportunities at the company outside of the U.S.

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

Novo Nordisk A/S (NYSE: NVO) is one of the top oversold NYSE stocks to buy now. In a report released on August 4, Emily Field from Barclays maintained a Hold rating on Novo Nordisk A/S (NYSE:NVO), ...

Maybe you stock up on ice cream after a difficult day at work or reach for chocolate after a disagreement with your partner.

For the quarter ended June 2025, Adient (ADNT) reported revenue of $3.74 billion, up 0.7% over the same period last year. EPS ...

Lyft (LYFT) reported $1.59 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 10.6 ...